Stephen A Sherwin's Net Worth

$29.6 Million

Estimate Recalculated Nov 8, 2024 09:38PM EST

Who is Stephen A Sherwin

Stephen A Sherwin has an estimated net worth of $29.6 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., NEUROCRINE BIOSCIENCES INC, BIOSANTE PHARMACEUTICALS INC, Verastem, Inc., ADURO BIOTECH, INC., Neon Therapeutics, Inc., BioPlus Acquisition Corp., RIGEL PHARMACEUTICALS INC, VICAL INC, Epiphany Technology Acquisition Corp., and CELL GENESYS INC.

SEC CIK

Stephen A Sherwin's CIK is 0001079462

Past Insider Trading and Trends

2004 was Stephen A Sherwin's most active year for acquiring shares with 12 total transactions. Stephen A Sherwin's most active month to acquire stocks was the month of April. 2009 was Stephen A Sherwin's most active year for disposing of shares, totalling 16 transactions. Stephen A Sherwin's most active month to dispose stocks was the month of September. 2024 saw Stephen A Sherwin paying a total of $1,787,350.00 for 48,408 shares, this is the most they've acquired in one year. In 2024 Stephen A Sherwin cashed out on 84,199 shares for a total of $5,338,564.50, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN INC.

Investor
Updated Jun 25, 2024
Form 4
7.15%
1.34K
Jun 25, 2024
20.08K
Grant
Jun 21
Form 4
5.40%
960.00
Jun 28, 2023
18.74K
Grant
Jun 26
Form 4
8.01%
1.37K
Jun 17, 2022
18.47K
Grant
Jun 15
Form 4
4.75%
775.00
Jul 02, 2021
17.10K
Grant
Jul 01
Form 4
5.76%
890.00
Jun 05, 2020
16.33K
Grant
Jun 03
Form 4
-13.62%
-2.43K
$176.84
-$801.68
Mar 12, 2020
15.44K
Sale
ScheduledMar 11
Form 4
22.37%
1.16K
Jun 20, 2019
6.32K
Grant
Jun 19
Form 4
-14.13%
-850.00
Nov 05, 2018
5.16K
Grant
Oct 31
Form 4
17.14%
880.00
Jun 14, 2018
6.01K
Grant
Jun 12
Form 4
-14.20%
-850.00
Dec 05, 2017
5.13K
Grant
Nov 29
Form 4
21.40%
1.05K
Jun 09, 2017
5.98K
Grant
Jun 07
Form 4
-16.93%
-1.00K
Nov 14, 2016
4.91K
Grant
Nov 08
Form 4
21.88%
1.06K
Jun 09, 2016
5.91K
Grant
Jun 08
Form 4
16.75%
695.00
Jun 11, 2015
4.85K
Grant
Jun 10
Form 4
-29.74%
-6.28K
$234.75
-$2.10M
Mar 11, 2015
14.83K
Sale
ScheduledMar 06 - Mar 10
Form 4
-8.39%
-405.00
Dec 03, 2014
4.43K
Grant
Dec 01
Form 4
21.97%
870.00
Jun 16, 2014
4.83K
Grant
Jun 12
Form 4
-21.04%
-5.50K
$169.55
-$1.21M
Jan 06, 2014
20.64K
Sale
ScheduledJan 02
Form 4
49.15%
1.30K
Jun 13, 2013
3.96K
Grant
Jun 12
Form 4
-34.06%
-12.82K
$146.54
-$2.22M
Jun 04, 2013
24.83K
Sale
ScheduledJun 03
Form 4
-36.10%
-1.50K
$176.88
-$265.32K
Mar 25, 2013
2.66K
Sale
ScheduledMar 22
Form 4
-32.49%
-2.00K
$145.90
-$291.80K
Sep 05, 2012
4.16K
Sale
ScheduledSep 04
Form 4
48.85%
2.02K
Jun 11, 2012
6.16K
Grant
Jun 08
Form 4
-37.68%
-2.50K
$126.45
-$316.12K
Jun 05, 2012
4.14K
Sale
ScheduledJun 04
Form 4
-27.37%
-2.50K
$110.88
-$277.20K
Dec 20, 2011
6.64K
Sale
ScheduledDec 19
Form 4
46.51%
2.90K
Jun 02, 2011
9.14K
Grant
Jun 01
Form 4
1,147.00%
5.74K
Jun 10, 2010
6.24K
Grant
Jun 09
Form 4
36.83K
Mar 24, 2010
36.83K
Grant
Mar 22
Form 3
Mar 24, 2010
Showing 29 results

NEUROCRINE BIOSCIENCES INC

Investor
Updated Nov 07, 2024
Form 4
-7.55%
-2.00K
Nov 07, 2024
24.50K
Grant
Nov 04
Form 4
-60.15%
-40.00K
$89.07
-$3.55M
May 30, 2024
26.50K
Sale
ScheduledMay 29
Form 4
2.87K
May 23, 2024
2.87K
Grant
May 22
Form 4
May 21, 2024
26.50K
Options
May 17
Form 4
-10.98%
-2.75K
Nov 20, 2023
22.31K
Grant
Nov 16
Form 4
4.20K
May 19, 2023
4.20K
Grant
May 17
Form 4
-54.49%
-30.00K
$39.36
-$3.57M
Jan 05, 2023
25.06K
Sale
ScheduledJan 03
Form 4
9.72K
May 20, 2022
9.72K
Grant
May 18
Form 4
-37.45%
-15.00K
$23.60
-$1.12M
Jan 26, 2022
25.06K
Sale
ScheduledJan 24
Form 4
-7.39%
-2.00K
Dec 16, 2021
25.06K
Grant
Dec 14
Form 4
8.83K
May 20, 2021
8.83K
Grant
May 19
Form 4
-9.40%
-2.81K
Dec 07, 2020
27.06K
Grant
Dec 03
Form 4
6.02K
May 21, 2020
6.02K
Grant
May 19
Form 4
-37.20%
-17.69K
$99.39
-$1.76M
Apr 30, 2020
29.86K
Sale
ScheduledApr 28
Form 4
10.00K
May 23, 2019
10.00K
Grant
May 22
Form 4
-17.38%
-10.00K
$98.44
-$984.42K
Jun 13, 2018
47.55K
Sale
ScheduledJun 11
Form 4
12.50K
May 25, 2018
12.50K
Grant
May 24
Form 4
-2.26%
-1.33K
$25.15
-$105.73K
Apr 30, 2018
57.55K
Options
Apr 26
Form 4
15.00K
Jun 08, 2017
15.00K
Grant
May 22
Form 4
-2.60%
-1.17K
$23.50
$31.60
Feb 08, 2017
43.88K
Options
Feb 07
Form 4
15.00K
May 24, 2016
15.00K
Grant
May 20
Form 4
-3.16%
-982.00
$24.97
$33.48
Apr 18, 2016
30.05K
Options
Apr 14
Form 4
-9.97%
-1.78K
$22.48
$4.80
Jan 12, 2016
16.03K
Options
Apr 07
Form 4
25.00K
Jun 01, 2015
25.00K
Grant
May 28
Form 4
15.00K
May 22, 2014
15.00K
Grant
May 22
Form 4
-79.26%
-10.72K
$13.11
$6.00
Apr 18, 2014
2.81K
Options
Apr 16
Form 4
15.00K
May 23, 2013
15.00K
Grant
May 23
Form 4
-87.24%
-10.47K
$11.38
$1.65
Apr 01, 2013
1.53K
Options
Mar 28
Form 4
15.00K
May 24, 2012
15.00K
Grant
May 23
Form 4
15.00K
May 25, 2011
15.00K
Grant
May 25
Form 4
15.00K
May 26, 2010
15.00K
Grant
May 25
Form 4
-100.00%
-24.00K
-$100.80
Sep 01, 2009
Disposition
Aug 28
Form 4
15.00K
Jun 01, 2009
15.00K
Grant
May 29
Form 4
15.00K
May 29, 2008
15.00K
Grant
May 28
Form 4
-100.00%
-12.00K
$0.01
-$99.60
Oct 26, 2007
Disposition
Oct 24
Form 4
12.00K
Jun 04, 2007
12.00K
Grant
Jun 01
Form 4
12.00K
Jun 30, 2006
12.00K
Grant
Jun 30
Form 4
12.00K
May 27, 2005
12.00K
Grant
May 25
Form 4
-50.00%
-2.50K
$15.28
-$122.50K
Sep 22, 2004
2.50K
Sale
Sep 22
Form 4
12.00K
$57.51
$690.12K
May 28, 2004
12.00K
Grant
May 26
Form 4
May 27, 2003
Showing 41 results

BIOSANTE PHARMACEUTICALS INC

Investor
Updated Mar 30, 2012
Form 4
25.00K
Mar 30, 2012
111.76K
Grant
Mar 30
Form 4
25.00K
Apr 01, 2011
111.76K
Grant
Mar 31
Form 4
10.00K
Apr 02, 2010
102.24K
Grant
Mar 31
Form 4
220.12K
Oct 15, 2009
220.12K
Grant
Oct 14
Form 3
Oct 15, 2009
Showing 5 results

Verastem, Inc.

Investor
Updated Jun 16, 2015
Form 4
17.97K
Jun 16, 2015
17.97K
Grant
Jun 12
Form 4
2.50K
$8.56
$21.40K
Dec 29, 2014
2.50K
Purchase
Dec 26
Form 4
25.00K
Jun 11, 2014
25.00K
Grant
Jun 10
Form 4
15.62K
Jun 06, 2013
15.62K
Grant
Jun 04
Form 4
25.00K
Mar 06, 2013
25.00K
Grant
Mar 05
Form 3
Mar 06, 2013
Showing 6 results

ADURO BIOTECH, INC.

Investor
Updated May 28, 2020
Form 4
30.00K
May 28, 2020
30.00K
Grant
May 05
Form 4
30.00K
May 15, 2019
30.00K
Grant
May 14
Form 4
20.00K
Jun 08, 2018
20.00K
Grant
Jun 06
Form 4
13.00K
Jun 12, 2017
13.00K
Grant
Jun 08
Form 4
13.00K
Jun 10, 2016
13.00K
Grant
Jun 09
Form 4
15.00K
Jun 26, 2015
15.00K
Grant
Jun 25
Form 3
Jun 26, 2015
36.30K
Showing 7 results

Neon Therapeutics, Inc.

Investor
Updated May 06, 2020
Form 4
-100.00%
-82.50K
May 06, 2020
Disposition
May 06
Form 4
18.50K
Jun 27, 2019
18.50K
Grant
Jun 25
Form 3
Jun 26, 2018
45.00K
Showing 3 results

BioPlus Acquisition Corp.

Investor
Updated Dec 02, 2021
Form 3
Dec 02, 2021
Showing 1 results

RIGEL PHARMACEUTICALS INC

Investor
Updated May 12, 2016
Form 4
40.00K
May 12, 2016
40.00K
Grant
May 11
Form 4
40.00K
May 14, 2015
40.00K
Grant
May 13
Form 4
30.00K
May 23, 2014
30.00K
Grant
May 21
Form 4
15.00K
May 28, 2013
15.00K
Grant
May 15
Form 4
15.00K
May 24, 2012
15.00K
Grant
May 23
Form 4
15.00K
May 20, 2011
15.00K
Grant
May 20
Form 4
15.00K
May 28, 2010
15.00K
Grant
May 28
Form 4
10.00K
May 29, 2009
10.00K
Grant
May 29
Form 4
10.00K
May 30, 2008
10.00K
Grant
May 30
Form 4
10.00K
Jun 01, 2007
10.00K
Grant
Jun 01
Form 4
4.04K
Aug 08, 2006
4.04K
Grant
Aug 07
Form 4
10.00K
Jun 01, 2006
10.00K
Grant
May 31
Form 4
10.00K
Jun 03, 2005
10.00K
Grant
Jun 03
Form 4
1.67K
Jun 14, 2004
1.67K
Grant
Jun 11
Form 4
8.33K
Jun 04, 2004
8.33K
Grant
Jun 03
Form 4/A
15.96K
Jan 29, 2004
15.96K
Grant
Jan 26 - Jan 28
Form 4
15.96K
Jan 28, 2004
15.96K
Grant
Jan 26 - Jan 28
Form 4
Jul 30, 2003
6.92K
Acq/Dis
Jul 28
Showing 18 results

VICAL INC

Investor
Updated May 26, 2015
Form 4
396.47%
57.50K
$0.01
$75.00
May 26, 2015
72.00K
Grant
May 21
Form 4
821.08%
57.50K
$0.01
$75.00
May 23, 2014
64.50K
Grant
May 22
Form 4
47.18K
$0.01
$70.03
May 28, 2013
47.18K
Purchase
May 23
Form 3
May 28, 2013
Showing 4 results

Epiphany Technology Acquisition Corp.

Investor
Updated Oct 04, 2022
Form 3
Oct 04, 2022
Showing 1 results

CELL GENESYS INC

Chairman and CEO
Updated Oct 15, 2009
Form 4
-100.00%
-1.49M
Oct 15, 2009
Disposition
Oct 14
Form 4
375.00K
Feb 08, 2008
375.00K
Grant
Feb 06
Form 4
12.01%
50.00K
Aug 01, 2007
496.25K
Grant
Jul 30
Form 4
100.00K
Feb 09, 2007
100.00K
Grant
Feb 07
Form 4
60.00K
Feb 09, 2006
60.00K
Grant
Feb 07
Form 4
-2.97%
-12.50K
Dec 22, 2005
438.95K
Grant
Dec 21
Form 4
0.60%
2.50K
$4.96
$12.40K
Jun 08, 2005
449.47K
Purchase
Jun 08
Form 4
$4.13
$41.25K
Mar 14, 2005
454.74K
Options
Mar 11
Form 4
112.50K
Feb 04, 2005
112.50K
Grant
Feb 03
Form 4
3.64%
15.27K
$8.66
$139.56K
Sep 14, 2004
435.22K
Acquisition
Feb 02 - Sep 13
Form 4
6.52%
60.00K
$14.04
$842.40K
Feb 03, 2004
980.00K
Grant
Feb 02
Form 4
-1.55%
-7.00K
Oct 06, 2003
445.95K
Grant
Oct 06
Form 4
-2.31%
-10.00K
Aug 04, 2003
452.95K
Grant
Aug 04
Form 4
0.14%
604.00
$8.08
$4.88K
Aug 04, 2003
462.95K
Acquisition
Aug 01
Showing 14 results